Abang, Zamiah .

HRN: 24-82-27  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/18/2024
CEFUROXIME 500MG (TAB)
03/18/2024
03/24/2024
ORAL
500mg
BID
Sp RMLE With Repair
Waiting Final Action 
03/30/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/30/2024
04/09/2024
IV
4.5gm
Q6
CAP HR
Waiting Final Action 
04/06/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
04/07/2024
04/09/2024
IV
4.5g
Q6h
ARDS; HAP
Checking Final Appropriateness 
04/06/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
04/06/2024
04/06/2024
IV
4.5g
Q6h
ARDS, HAP
Checking Final Appropriateness 
04/06/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
04/06/2024
04/09/2024
IV
4.5g
Q6h
ARDS, HAP
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: